All Work

Jon C. Ogg

BioWatch: Curis Gets Further on Cancer Map (CRIS)

Curis Inc. (NASDAQ: CRIS) is not exactly a household name, even when it comes to the land of biotech investors.  The company has come under focus today after announcing that it is presenting data…

Jon C. Ogg · 15 years ago

Does American Apparel Have Any Buyout Value? (APP)

This morning there is an interesting take out there regarding American Apparel Inc. (AMEX: APP).  PEHub.com has reported that American Apparel is working with Rothschild as advisor to help it explore a sale.  CEO…

Jon C. Ogg · 15 years ago

Looking for Value Stocks (BBY, DPZ, JKS)

After the markets have been on fire and after valuation concerns are starting to grow among investors in a world full of international strife, maybe it is time to consider value stocks.  We have…

Jon C. Ogg · 15 years ago

Apple Chart Watch: The Inevitable Breakdown (AAPL)

Apple Inc. (NASDAQ: AAPL) is in trouble on its stock charts.  Its stock has now fallen five days in a row, a feat not seen in months.  Pure technical analysis does not care about…

Jon C. Ogg · 15 years ago

Crush Depth Alert in American Superconductor (AMSC)

American Superconductor Corporation (NASDAQ: AMSC) is hardly looking super and hardly looking American after the close of trading this Tuesday.  The company gave a guidance update due to a key customer order refusal and…

Jon C. Ogg · 15 years ago

Will Intel Warn on Earnings? (INTC, SMH, AMD)

Intel Corporation (NASDAQ: INTC) has been the beneficiary of the great  NASDAQ 100 rebalancing act, but things have been a bit rough for holders of late.  Last Friday we noted how the Semiconductor HOLDRs (NYSE:…

Jon C. Ogg · 15 years ago

IPO Watch: LinkedIn Amends IPO Filing (GS, MHP, SAP)

LinkedIn Corporation has filed its second amended registration statement with the SEC regarding its upcoming Initial Public Offering.  There is still no size nor any indicated price range.  A ticker symbol is not disclosed…

Jon C. Ogg · 15 years ago

BioWatch: Cubist Moves Beyond Patent Fears (CBST, TEVA)

Cubist Pharmaceuticals Inc. (NASDAQ: CBST) is going to be back in favor now that it has settled a key patent case against Teva Pharmaceutical Industries Limited (NASDAQ: TEVA).  The company announced that it will grant…

Jon C. Ogg · 15 years ago